ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$1.32
+0.02 (+1.54%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,368.2% upside
Low Target $17.80
Average Target $32.58
High Target $40.39
Current Price $1.32
Current
$1.32
Target
$32.58
$17.80 $32.58 avg $40.39
Scenario Analysis
Bear Case
$17.80
1,248.5%
Low target
Base Case
$32.58
+2,368.2%
Avg target
Bull Case
$40.39
+2,959.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.35
-43.8% from high
52-Week Low
$0.77
+71.7% from low
Target vs 52W High
$32.58
+1,286.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%